The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.
The largest deal of the week is Humana’s acquisition of the remaining stake in Kindred at Home, valued at $5.7 billion, including debt, from TPG Capital and Welsh, Carson, Anderson & Stowe. The three companies bought Kindred together in 2017 deal valued at $4.1 billion. Including Humana’s initial investment in 2017, the company has paid $7.1 billion overall for Kindred at Home.
Kindred at Home employs approximately 43,000 caregivers providing home health, hospice, and community care services to over 550,000 patients annually. Kindred at Home has locations in 40 states, providing extensive geographic coverage with approximately 65 percent overlap with Humana’s individual Medicare Advantage membership. As part of the transaction, Kindred at Home’s home health operations will be integrated into Humana’s Home Solutions business, Centerwell. The acquisition is expected to close in Q3:21.
To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.
|Pfizer Inc.||Amplyx Pharmaceuticals, Inc.||N/A|
|Holmusk||Otsuka Health Solutions||N/A|
|Paya Holdings Inc.||Paragon Payments Solutions||N/A|
|Home Health Care & Hospice|
|Humana Inc.||Kindred at Home||$5,700,000,000|
|Encompass Health Corp.||Frontier Home Health and Hospice assets||N/A|
|Valeo Home Health & Hospice||Hearts for Hospice & Home Health||N/A|
|LHC Group, Texas Health Resources, & Methodist Health System||Regent Home Health||N/A|
|Laboratories, MRI and Dialysis|
|DispatchHealth||Professional Portable X-Ray||N/A|
|The Carlyle Group LP||Unchained Labs||$435,000,000|
|Castle Biosciences, Inc.||Myriad myPath Melanoma, LLC, Laboratory||$32,500,000|
|Augustus Labs LLC||Evergreen-Sheridan Laboratories||N/A|
|Arcline Investment Management||Polypeptide Therapeutic Solutions, S.L.||N/A|
|DJO, LLC||MedShape, Inc.||N/A|
|Physician Medical Groups|
|U.S. Oral Surgery Management||Oral and Maxillofacial Surgery Associates||N/A|
|Northwest Medical Specialties, PLLC||Osborn Cancer Care||N/A|
|Bryan Physician Network||The Surgery Group of Grand Island||N/A|
|Hunter Street Partners & Healy Capital Partners||Kirkpatrick Dental Group||N/A|
|Eye Health America||The Eye Care Center||N/A|
|dMed Global||Clinipace Incorporated||N/A|